By PPN News Staff
The FDA granted final approval of amiodarone hydrochloride tablets (Aurobindo Pharma), a generic version of Wyeth’s Cordarone.
The new product will be available in a 200-mg tablet.
Amiodarone hydrochloride tablets, 200 mg, is indicated for the treatment of recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia (VT). Although there are other causes, VT frequently occurs in those with structural heart disease. It is associated with
AUGUST 23, 2016